Malaria: all 1,315 studies
Page 9 of 14. Open to participants first (86), then studies with results posted, then the rest; newest registration first within each.
- Artemisinin-Based Antimalarial Combinations and Clinical Response in CameroonCompletedNCT01845701Phase 3
- Rapid Diagnostic Tests for Assessment of Initial Clearance and Detection of Recurrent Malaria InfectionsCompletedNCT01843764
- A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic ReagentsWithdrawnNCT01843491Phase 1
- Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic CarriersCompletedNCT01838902Phase 3
- Safety and Efficacy of Primaquine for P. VivaxStatus unknownNCT01837992Not applicable
- Impact of a Parenting Program in Liberia to Improve Parenting, Education, and Health Outcomes for Children in LiberiaCompletedNCT01829815Not applicable
- Malaria Transmission Studies in MaliCompletedNCT01829737
- Malaria Treatment With Injectable ArteSunateCompletedNCT01828333
- Phase Ia Study of ChAd63/MVA PvDBPCompletedNCT01816113Phase 1
- IMPROV (Improving the Radical Cure of Vivax Malaria)CompletedNCT01814683Not applicable
- Pharmacokinetic Study of Multi-dose ChloroquineCompletedNCT01814423Phase 4
- Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western KenyaWithdrawnNCT01810731Phase 2/3
- Sustainable Financial Incentives To Improve Prescription Practices For MalariaCompletedNCT01809873Not applicable
- Intravenous Artesunate and MalariaStatus unknownNCT01805232Phase 4
- Parasitic Clearance and Recurrence Rates Among Patients With Vivax MalariaStatus unknownNCT01784315
- Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin ProphylaxisWithdrawnNCT01783340Phase 1/2
- Evaluation of Vitamin A and Zinc Supplementation on Malarial MorbidityCompletedNCT01782001Phase 3
- Primaquine Pharmacokinetics in Lactating Women and Their InfantsCompletedNCT01780753Phase 1
- Plasmodium Falciparum Artemisinin Resistance VietnamCompletedNCT01775592Phase 4
- Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune AdultsCompletedNCT01771848Phase 1
- Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi NigerCompletedNCT01755559Phase 4
- Acute vs. Delayed Iron: Effect on Red Cell Iron Incorporation in Severe MalariaCompletedNCT01754701Not applicable
- Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium FalciparumCompletedNCT01746199Phase 3
- Phase2a Primaquine Dose Escalation StudyCompletedNCT01743820Phase 2
- Computerized Cognitive Rehabilitation in Children After Severe MalariaCompletedNCT01743417Not applicable
- A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1CompletedNCT01739036Phase 1/2
- Artemisinin-resistant Malaria in CambodiaCompletedNCT01736319
- Pharmacology of Antimalarial Therapy With or Without Antiretroviral TherapyTerminatedNCT01728961Phase 4
- Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine ProphylaxisCompletedNCT01728701Phase 1
- Antimalarial Pharmacology in Children and Pregnant Women in UgandaCompletedNCT01717885
- Safety and Efficacy of Chloroquine and Primaquine for Vivax Malaria in BhutanCompletedNCT01716260
- Impact of Insecticide Resistance on Vector ControlStatus unknownNCT01713517Phase 4
- P. Knowlesi Trial of Artesunate-mefloquine Versus ChloroquineCompletedNCT01708876Phase 3
- SPK Study in AfghanistanCompletedNCT01707199Not applicable
- Improving Anti-malarial Treatment Options in Guinea-Bissau - Part ACompletedNCT01704508Phase 4
- ANC & Malaria Diagnostic in PregnancyCompletedNCT01703884Phase 4
- The Combined Use of Indoor Residual Spraying (IRS) and Long-lasting Insecticidal Nets (LLINs) for Malaria PreventionStatus unknownNCT01697852Phase 4
- Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina FasoCompletedNCT01697787Phase 4
- Ethiopia Antimalarial in Vivo Efficacy Study 2012CompletedNCT01680406Phase 4
- Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in KenyaCompletedNCT01669941Phase 4
- Adjuvanting Viral Vectored Malaria Vaccines With Matrix MCompletedNCT01669512Phase 1
- Efficacy of Malaria Vaccines in Kenyan AdultsCompletedNCT01666925Phase 2
- Repellents as Added Control Measure to Long Lasting Insecticidal NetsCompletedNCT01663831Not applicable
- Comparison of Two Antimalarial Drugs Regimens in Patient With Plasmodium Vivax Malaria in ThailandStatus unknownNCT01662700Phase 4
- Re-exposure of Human Volunteers to a Heterologous Strain of P. Falciparum SporozoitesCompletedNCT01660854Not applicable
- Efficacy of Artesunate-Mefloquine Combination Therapy in Trat Province, ThailandCompletedNCT01659281Not applicable
- Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School ChildrenCompletedNCT01658774Not applicable
- Efficacy of Candidate Malaria Vaccines in Senegalese AdultsCompletedNCT01658696Phase 2
- Feasibility and Impact of Malaria Rapid Diagnostic Tests in the African Retail SectorCompletedNCT01652365Not applicable
- Seasonal Malaria Chemoprevention Versus Home Management of Malaria in Children Under 5 Years in GhanaCompletedNCT01651416Phase 4
- Phase 1b Malaria Clinical Trial Using Argemone Mexicana in Healthy Adults in MaliStatus unknownNCT01645254Phase 1
- Paracetamol Effect on Oxidative Stress and Renal Function in Severe MalariaCompletedNCT01641289Not applicable
- A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina FasoCompletedNCT01635647Phase 1/2
- Efficacy of Iron Fortified Complementary Food and IPT of Malaria in Young Children in Côte d'IvoireCompletedNCT01634945Not applicable
- Comparison of Three Plasmodium Falciparum Isolates in a Controlled Human Malaria InfectionCompletedNCT01627951Not applicable
- Artemether/Lumefantrine and Vivax MalariaCompletedNCT01625871Phase 3
- Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune AdultsCompletedNCT01624961Phase 1
- Malaria Prevention CambodiaTerminatedNCT01624337Not applicable
- A Challenge Study to Assess the Protective Efficacy of Two Malaria Vaccine CandidatesCompletedNCT01623557Phase 1/2
- Trial for Malaria Vaccine Candidate, PfPEBS (P. Falciparum Pre-Erythrocytic and Blood Stage)Status unknownNCT01605786Phase 1/2
- Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria TransmissionCompletedNCT01603251Phase 1/2
- Exposure of Naive and Pre-immune Subjects to P. Vivax ChallengeCompletedNCT01585077Phase 1/2
- Reducing the Burden of Malaria by Targeting Hotspots of Malaria TransmissionCompletedNCT01575613Not applicable
- Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated MalariaCompletedNCT01567423Not applicable
- Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,SCompletedNCT01556945Phase 1/2
- Malaria Rapid Diagnostic Tests (RDTs) in Pregnancy: Detection of Placental MalariaCompletedNCT01555255
- Sanaria™ PfSPZ Challenge VaccineCompletedNCT01546389Phase 1
- Study of the Environmental Factors Modulating Children Immune Response in Northern SenegalCompletedNCT01545115
- Controlled Human Malaria Infection by Intradermal Injection of Plasmodium Falciparum Sporozoites in Tanzanian AdultsCompletedNCT01540903Phase 1
- Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infectionCompletedNCT01524341Phase 2
- Apheresis to Obtain Plasma and White Blood Cells in MaliesWithdrawnNCT01511601
- Malaria Challenge in Healthy VolunteersCompletedNCT01500980Phase 1
- Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in ChildrenCompletedNCT01464138Phase 2
- Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in AdultsStatus unknownNCT01464125Phase 2
- Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, GhanaStatus unknownNCT01459146Phase 4
- Insecticide Treated Polyethylene Sheeting for Prevention of Malaria in EmergenciesCompletedNCT01456858Phase 3
- Intermittent Parasite Clearance (IPC) in Schools: Impact on Malaria, Anaemia and CognitionCompletedNCT01454752Not applicable
- AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Children in a Malaria Endemic AreaCompletedNCT01450293Phase 1
- Safety and Immunogenicity of New Malaria Vaccine Candidate ChAd63 CS Administered Alone and With MVA CSCompletedNCT01450280Phase 1
- Trial of Malaria Seasonal IPTc Combined With Community Case ManagementCompletedNCT01449045Phase 3
- Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated MalariaTerminatedNCT01445938Phase 2
- Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum MalariaTerminatedNCT01442168Phase 1/2
- Experimental PfSPZ Vaccine in Adults Without MalariaCompletedNCT01441167Phase 1
- Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)CompletedNCT01434381Phase 1
- Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in KenyaCompletedNCT01425073Not applicable
- Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine ProphylaxisCompletedNCT01422954Not applicable
- Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in ChildrenCompletedNCT01407887Phase 2
- Cluster Randomised Trial of Malaria RDTs Used by CHWs in AfghanistanCompletedNCT01403350Phase 4
- A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge ModelCompletedNCT01397227Phase 1/2
- Dihydroartemisinin-piperaquine and Primaquine for Uncomplicated Plasmodium Falciparum CasesCompletedNCT01392014Phase 4
- Impact of Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in Lampung Province, SumatraCompletedNCT01389557Phase 4
- Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in ChildrenCompletedNCT01388842Phase 2
- Safety and Immunogenicity of AdCh63 ME-TRAP and MVA ME-TRAP Vaccines in Malaria Endemic AreasCompletedNCT01379430Phase 1
- Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax MalariaCompletedNCT01378286Phase 3
- Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated MalariaCompletedNCT01374581Phase 3
- Azithromycin Combination Therapy for the Treatment of Severe MalariaCompletedNCT01374126Phase 2
- AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Adults and Children in a Malaria Endemic AreaCompletedNCT01373879Phase 1
- Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in UgandaCompletedNCT01365598Phase 3
- Safety and Immunogenicity of Novel Vaccination Schedules With Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAPCompletedNCT01364883Phase 1
- Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum MalariaStatus unknownNCT01361269Phase 2